The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...

New industrial development initiatives are under way in Alabama and Texas. While a Norfolk Southern (NS)-served site in ...

Musculoskeletal disorders and injuries are a leading cause of disability worldwide, severely affecting quality of life and creating a significant ...

StemRIM Inc. ( ($JP:4599) ) has shared an announcement. StemRIM Inc. reported its financial results for the three months ending October 31, 2025, ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

Photoactive nanomaterials represent a dynamic and rapidly evolving area within nanobiotechnology, offering unique opportunities to manipulate cellular and ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...